GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxcyte Inc (FRA:5VA) » Definitions » Investments And Advances

Vaxcyte (FRA:5VA) Investments And Advances : €380.19 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Vaxcyte Investments And Advances?

Vaxcyte's Investments And Advances for the quarter that ended in Mar. 2024 was €380.19 Mil.

Vaxcyte's quarterly Investments And Advances declined from Sep. 2023 (€157.94 Mil) to Dec. 2023 (€149.17 Mil) but then increased from Dec. 2023 (€149.17 Mil) to Mar. 2024 (€380.19 Mil).

Vaxcyte's annual Investments And Advances increased from Dec. 2021 (€24.00 Mil) to Dec. 2022 (€25.06 Mil) and increased from Dec. 2022 (€25.06 Mil) to Dec. 2023 (€149.17 Mil).


Vaxcyte Investments And Advances Historical Data

The historical data trend for Vaxcyte's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaxcyte Investments And Advances Chart

Vaxcyte Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Investments And Advances
Get a 7-Day Free Trial - - 24.00 25.06 149.17

Vaxcyte Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 119.38 141.89 157.94 149.17 380.19

Vaxcyte Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Vaxcyte (FRA:5VA) Business Description

Industry
Traded in Other Exchanges
Address
825 Industrial Road, Suite 300, San Carlos, CA, USA, 94070
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-XP, VAX-A1, and VAX-PG.

Vaxcyte (FRA:5VA) Headlines

No Headlines